Login
Home
Charts
Search
Watchlist
Products

NGL Fine Chem Ltd

NGLFINE·NSE
₹2,830.40-1.01%Wed, 23 Sept '26
Industry:Pharma - Animal
Indices:

NGL Fine Chem Ltd

NGLFINE
NSE
₹2,830.40
-1.01%
|Wed, 23 Sept '26
SOICxStockScans Reports
Industry
Pharma - Animal
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,754Cr
Close
Close Price
₹2,839.70
Industry
Industry
Pharma - Animal
PE
Price To Earnings
30.67
PS
Price To Sales
3.27
Revenue
Revenue
₹536Cr
Rev Gr TTM
Revenue Growth TTM
40.45%
PAT Gr TTM
PAT Growth TTM
174.13%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
808810091938995104120128149139
Growth YoY
Revenue Growth YoY%
18.422.332.827.716.61.3-4.814.828.643.157.133.6
Expenses
ExpensesCr
6674848182848993103105128116
Operating Profit
Operating ProfitCr
141416912561117222123
OPM
OPM%
17.415.815.910.312.45.76.710.514.317.514.316.7
Other Income
Other IncomeCr
344650-162527
Interest Expense
Interest ExpenseCr
000001111111
Depreciation
DepreciationCr
333333345555
PBT
PBTCr
1414161213111213211824
Tax
TaxCr
344340133546
PAT
PATCr
10101291011910161318
Growth YoY
PAT Growth YoY%
124.454.532.28.3-6.4-87.2-95.60.2-1.81,125.82,398.299.1
NPM
NPM%
13.111.412.310.210.51.40.68.98.012.39.013.2
EPS
EPS₹
17.016.219.914.915.92.10.915.015.625.421.829.8
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
808810091938995104120128149139
Growth YoY
Revenue Growth YoY%
18.422.332.827.716.61.3-4.814.828.643.157.133.6
Expenses
ExpensesCr
6674848182848993103105128116
Operating Profit
Operating ProfitCr
141416912561117222123
OPM
OPM%
17.415.815.910.312.45.76.710.514.317.514.316.7
Other Income
Other IncomeCr
344650-162527
Interest Expense
Interest ExpenseCr
000001111111
Depreciation
DepreciationCr
333333345555
PBT
PBTCr
1414161213111213211824
Tax
TaxCr
344340133546
PAT
PATCr
10101291011910161318
Growth YoY
PAT Growth YoY%
124.454.532.28.3-6.4-87.2-95.60.2-1.81,125.82,398.299.1
NPM
NPM%
13.111.412.310.210.51.40.68.98.012.39.013.2
EPS
EPS₹
17.016.219.914.915.92.10.915.015.625.421.829.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
153152258318278339368501536
Growth
Revenue Growth%
-1.070.123.1-12.421.88.736.040.5
Expenses
ExpensesCr
121132178250244285334428452
Operating Profit
Operating ProfitCr
321980683453347384
OPM
OPM%
20.912.830.921.412.315.79.214.515.7
Other Income
Other IncomeCr
4381161491517
Interest Expense
Interest ExpenseCr
222211244
Depreciation
DepreciationCr
688101112122021
PBT
PBTCr
281278672754286376
Tax
TaxCr
74211771371519
PAT
PATCr
20857502141214857
Growth
PAT Growth%
-58.6580.5-12.0-58.9101.6-48.9127.8174.1
NPM
NPM%
13.15.522.015.77.412.25.79.610.7
EPS
EPS₹
32.613.591.880.833.266.934.277.992.6
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
153152258318278339368501536
Growth
Revenue Growth%
-1.070.123.1-12.421.88.736.040.5
Expenses
ExpensesCr
121132178250244285334428452
Operating Profit
Operating ProfitCr
321980683453347384
OPM
OPM%
20.912.830.921.412.315.79.214.515.7
Other Income
Other IncomeCr
4381161491517
Interest Expense
Interest ExpenseCr
222211244
Depreciation
DepreciationCr
688101112122021
PBT
PBTCr
281278672754286376
Tax
TaxCr
74211771371519
PAT
PATCr
20857502141214857
Growth
PAT Growth%
-58.6580.5-12.0-58.9101.6-48.9127.8174.1
NPM
NPM%
13.15.522.015.77.412.25.79.610.7
EPS
EPS₹
32.613.591.880.833.266.934.277.992.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333
Reserves
ReservesCr
8996151200219260279326
Current Liabilities
Current LiabilitiesCr
384342665887118150
Non Current Liabilities
Non Current LiabilitiesCr
1212118663466
Total Liabilities
Total LiabilitiesCr
142154207277287356435546
Current Assets
Current AssetsCr
7981125173163213234276
Non Current Assets
Non Current AssetsCr
637383103124143201269
Total Assets
Total AssetsCr
142154207277287356435546
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333
Reserves
ReservesCr
8996151200219260279326
Current Liabilities
Current LiabilitiesCr
384342665887118150
Non Current Liabilities
Non Current LiabilitiesCr
1212118663466
Total Liabilities
Total LiabilitiesCr
142154207277287356435546
Current Assets
Current AssetsCr
7981125173163213234276
Non Current Assets
Non Current AssetsCr
637383103124143201269
Total Assets
Total AssetsCr
142154207277287356435546

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
920271435203243
Investing Cash Flow
Investing Cash FlowCr
-10-20-25-14-27-27-70-71
Financing Cash Flow
Financing Cash FlowCr
0-1-1-1-1-13730
Net Cash Flow
Net Cash FlowCr
-102-17-702
Free Cash Flow
Free Cash FlowCr
-6610-155-8-41-43
CFO To PAT
CFO To PAT%
44.0245.548.227.7172.249.5153.190.0
CFO To EBITDA
CFO To EBITDA%
27.6105.534.320.4102.838.495.559.6
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
920271435203243
Investing Cash Flow
Investing Cash FlowCr
-10-20-25-14-27-27-70-71
Financing Cash Flow
Financing Cash FlowCr
0-1-1-1-1-13730
Net Cash Flow
Net Cash FlowCr
-102-17-702
Free Cash Flow
Free Cash FlowCr
-6610-155-8-41-43
CFO To PAT
CFO To PAT%
44.0245.548.227.7172.249.5153.190.0
CFO To EBITDA
CFO To EBITDA%
27.6105.534.320.4102.838.495.559.6

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2901579471,2107401,2926891,2801,754
Price To Earnings
Price To Earnings
14.418.816.724.236.131.332.626.630.7
Price To Sales
Price To Sales
1.91.03.73.82.73.81.92.63.3
Price To Book
Price To Book
3.11.66.16.03.34.92.43.95.3
EV To EBITDA
EV To EBITDA
9.79.112.018.222.124.822.419.022.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.537.647.336.732.235.230.433.733.7
OPM
OPM%
20.912.830.921.412.315.79.214.515.7
NPM
NPM%
13.15.522.015.77.412.25.79.610.7
ROCE
ROCE%
25.911.848.029.611.318.98.415.515.5
ROE
ROE%
21.98.436.724.69.215.77.514.614.6
ROA
ROA%
14.25.427.418.07.111.64.98.88.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2901579471,2107401,2926891,2801,754
Price To Earnings
Price To Earnings
14.418.816.724.236.131.332.626.630.7
Price To Sales
Price To Sales
1.91.03.73.82.73.81.92.63.3
Price To Book
Price To Book
3.11.66.16.03.34.92.43.95.3
EV To EBITDA
EV To EBITDA
9.79.112.018.222.124.822.419.022.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.537.647.336.732.235.230.433.733.7
OPM
OPM%
20.912.830.921.412.315.79.214.515.7
NPM
NPM%
13.15.522.015.77.412.25.79.610.7
ROCE
ROCE%
25.911.848.029.611.318.98.415.515.5
ROE
ROE%
21.98.436.724.69.215.77.514.614.6
ROA
ROA%
14.25.427.418.07.111.64.98.88.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — NGL Fine Chem Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/l8uxbdqytc7pp4b5rw21y479.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/w73w6ly3x4juczl40y2c5vfa.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/lmmmj5l65fk67br6jtx4alqw.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/49ujpub5zptdbmq3eqony615.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/acdpey4x3r7ueaxap1gbfwl1.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/1t3nqqpulo0kedkn1kvoinul.pdf
  • Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/99ze8b61x33qyjse4wxa3yla.pdf
  • Q2 FY2023 Earnings Call Transcript (Sep 2022, PDF): https://www.stockscans.in/document/49bov10umn2wwtcji38baz7b.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/30b2o34q3tinda98skim3pwk.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/9a2zteafvi1jx1qv70i0esc9.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/x3ylvvdxffgh8sgvi1u9ece3.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/6aqmo5dqws2rmhtkmzupoljm.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/9123wbp23aa61bmfatb54cf2.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/p3d4xoy2czinre2zz6584aqr.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/b4bnqukvosogv4t0ebx58j6n.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/bebymyo72a4pdij0qzvzzo2w.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/7cly4n31z9uyyphyoqsafwtw.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/5ecjml3v504a2z3ixrzts0hf.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/wx0iawnhamqtfbqaz1ygix6o.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/e8tp589izjvbbksomrn85f60.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/20do6kzp60t2xey10ajbghkr.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/bk5t2pzwkrls8n8bf7n85lvw.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/oevo2bmpvvbhu6yf3m6y4vzf.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/kgwquvjnpr7kquiyajmxl0le.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/eu38ypjzkc6clgm1dr0gkbqi.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/f68v3b90usc9235gy2r54xye.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/shuz2bk97qw3km8okuj2klfd.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/43ebciqgoc85h0w8otukfrby.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/3hw8zdvtioiah9xj3q06iz5y.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/oc3t5i51a39rwk6jbzvx1tls.pdf

Concall Transcript Summaries — NGL Fine Chem Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202603/l8uxbdqytc7pp4b5rw21y479.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202509/w73w6ly3x4juczl40y2c5vfa.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202503/lmmmj5l65fk67br6jtx4alqw.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202409/49ujpub5zptdbmq3eqony615.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202403/acdpey4x3r7ueaxap1gbfwl1.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202309/1t3nqqpulo0kedkn1kvoinul.pdf
  • Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202303/99ze8b61x33qyjse4wxa3yla.pdf
  • Q2 FY2023 Concall Transcript Summary (Sep 2022): https://www.stockscans.in/company/NSE%3ANGLFINE/transcript-notes/202209/49bov10umn2wwtcji38baz7b.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies